LEXINGTON, Mass.--(BUSINESS WIRE)--RainDance Technologies, Inc., today announced the appointment of Laura L. Deming as Senior Vice President of Product Development. In her new role, Ms. Deming will oversee the long-range product planning process and provide overall leadership for product strategy, development and delivery across all of the company’s advanced microdroplet-based technologies for the life science and research markets. Ms. Deming will report to Roopom Banerjee, RainDance’s President and CEO. The Company also announced that Joseph E. Malandrakis has been engaged as senior product development counsel.
“At RainDance, we are bringing together a world-class team of proven leaders who are passionate about developing and commercializing disruptive technologies and transforming them into customer-friendly products,” said Banerjee. “As we continue to expand high-growth applications for our innovative microdroplet platform, Laura will play a pivotal role in designing, developing, and bringing to market all of our next-generation products. Joe also provides us a wealth of experience in product development and is a strong addition to the RainDance team.”
“RainDance is experiencing breakthrough growth and this is a very exciting time to join the Company. I look forward to working closely with this exceptionally talented team as we bring quality novel high-throughput platforms, and innovative digital PCR and single cell analysis solutions to customers around the world,” added Ms. Deming.
Ms. Deming joins RainDance with more than 25 years of experience in the development of instrumentation and consumables directed at genomics/proteomics research, in vitro diagnostics, cell analysis and therapeutic medical device applications. Prior to RainDance, she was Vice President of Research, Development and Operations at medical device startup WaveRx. Ms. Deming has also held senior Product Development and R&D roles at leading life science and diagnostics companies including Cytyc Corporation from 2000-2003, PerSeptive Biosystems (acquired by Applied Biosystems) from 1994-2000, and Millipore Corporation from 1985-1994. She holds a B.S. in Chemistry from Bridgewater State College, an M.S. in Chemical Engineering from the University of Lowell and an M.B.A. from Worcester Polytechnic Institute.
Mr. Malandrakis brings 35 years of industry experience to the RainDance team, including nearly 30 years at Applera Corporation (formerly Applied Biosystems). From 2001-2003, he was the Vice President of Global Services and Solutions at Applied Biosystems. From 1998-2001, Mr. Malandrakis managed Applera Corporation’s $300+ million acquisition of PerSeptive Biosystems. He also served as Vice President of North American Sales and Service as well as Vice President of Worldwide Operations at Applera Corporation. He holds an M.B.A. (Operations Research) from the University of Bridgeport and a B.S. in Industrial Engineering from the New York Institute of Technology.
“We are pleased to welcome Laura to RainDance,” said Michael Hunkapiller, Ph.D., General Partner at Alloy Ventures and Member of the RainDance Board of Directors. "Laura brings exceptional leadership, product development and global expertise to RainDance, as well as a well-earned reputation for building great teams and driving disciplined product development processes to build industry-leading products. I also worked with Joe for more than 20 years and believe he will help RainDance accelerate and enhance its product development programs."
RainDance’s microdroplet-based RainStorm™ technology enables researchers to perform fully automated and highly accurate biological analysis in important disease areas including cancer, infectious disease, immunology and genetic screening. Each RainStorm picoliter-scale droplet is the functional equivalent of an individual test tube and can contain a single molecule, cell or reaction. The company’s current commercial products integrate with all next-generation DNA sequencing platforms to provide unparalleled performance and a vastly simplified workflow, at a cost-effective price.
For more information about RainDance Technologies, please visit www.RainDanceTech.com.
About RainDance Technologies, Inc.
RainDance Technologies is pioneering the use of high-throughput microdroplet-based analysis in human health and life science research. The company's core RainStorm™ technology generates millions of discrete droplets that can encapsulate a single molecule, cell or reaction and be digitally analyzed and sorted one at a time. The power, simplicity and precision of microdroplets enable researchers to answer complex questions with unprecedented sensitivity and quantification. The complete RainDance solution includes automated instrumentation, customizable bioinformatics and high-value consumables and reagents for applications including targeted next-generation DNA sequencing, methylation, single molecule digital PCR and single cell analysis. Based in Lexington, Massachusetts, the company supports scientists around the world through its international sales and support operations and a global network of distributors and service providers. For more information, please visit www.RainDanceTech.com.
RainStorm is a trademark of RainDance Technologies, Inc.